Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that the officials of the Company will be interacting with Analyst/Institutional Investors on December 1, 2022 via in person meeting.
The above information is a part of company’s filings submitted to BSE.